EPCAM and neoplasm: As no quantitative information about the uptake of DARPin-based agents targeting EpCAM in SKOV-3 tumor model was available, we chose a wide range of concentrations based on our previous experience with other types of scaffold proteins, affibody molecules, and ADAPTs.